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Yersinia pestis survives and replicates in phagosomes of murine macrophages. Previous studies demonstrated
that Y. pestis-containing vacuoles (YCVs) acquire markers of late endosomes or lysosomes in naïve macrophages and that this bacterium can survive in macrophages activated with the cytokine gamma interferon. An
autophagic process known as xenophagy, which destroys pathogens in acidic autophagolysosomes, can occur
in naïve macrophages and is upregulated in activated macrophages. Studies were undertaken here to investigate the mechanism of Y. pestis survival in phagosomes of naïve and activated macrophages and to determine
if the pathogen avoids or co-opts autophagy. Colocalization of the YCV with markers of autophagosomes or
acidic lysosomes and the pH of the YCV were determined by microscopic imaging of infected macrophages.
Some YCVs contained double membranes characteristic of autophagosomes, as determined by electron microscopy. Fluorescence microscopy showed that ⬃40% of YCVs colocalized with green fluorescent protein
(GFP)-LC3, a marker of autophagic membranes, and that YCVs failed to acidify below pH 7 in naïve
macrophages. Replication of Y. pestis in naïve macrophages caused accumulation of LC3-II, as determined by
immunoblotting. While activation of infected macrophages increased LC3-II accumulation, it decreased the
percentage of GFP-LC3-positive YCVs (⬃30%). A viable count assay showed that Y. pestis survived equally well
in macrophages proficient for autophagy and macrophages rendered deficient for this process by Cre-mediated
deletion of ATG5, revealing that this pathogen does not require autophagy for intracellular replication. We
conclude that although YCVs can acquire an autophagic membrane and accumulate LC3-II, the pathogen
avoids xenophagy by preventing vacuole acidification.
Yersinia pestis is a gram-negative bacterium and the cause of
plague (32, 34). Zoonotic foci of plague exist in many parts of
the world, including North America. Y. pestis infections are
most commonly transmitted to humans by infected fleas and
typically develop into bubonic plague or, less frequently, into
septicemic plague (32). Plague infections in humans can also
result from contact with body fluids or from inhalation of
respiratory droplets from infected animals or humans. Inhalation of Y. pestis into the lungs can initiate primary pneumonic
plague.
Y. pestis is able to survive and replicate in murine macrophages in vitro (5, 6, 18, 35, 36, 44) and in vivo (23) and is
therefore classified as a facultative intracellular pathogen. Microscopic examination of tissues of animals experimentally infected with Y. pestis has shown the presence of plague bacilli
inside macrophages (11, 23, 25, 50). More often, however, Y,
pestis is detected as large numbers of extracellular bacteria in
tissues (20, 39, 51). Y. pestis produces several antiphagocytic
factors that are upregulated during growth at 37°C. These

factors include several Yop proteins and the LcrV protein and
their designated type III secretion system encoded on pCD1
(48). In addition, a capsule composed of the F1 protein is
maximally expressed after extended growth at 37°C and promotes resistance to phagocytosis (8). When grown at ambient
temperatures (e.g., 28°C), Y. pestis is efficiently phagocytosed
by macrophages (5). It has been hypothesized that when Y.
pestis growing at 28°C is introduced into a mammalian host, it
initially survives and replicates within macrophages that internalize the bacteria (5). Subsequently, the bacteria escape or
are released from dying macrophages and replicate in an extracellular niche (5).
After a macrophage engulfs a bacterium, the phagosome
changes rapidly into a less habitable compartment, termed a
phagolysosome, through a series of fusion events with endocytic compartments (49). Within 2 to 5 min after their formation, phagosomes transiently acquire characteristics of early
endosomes (49). After 10 to 30 min phagosomes begin to fuse
with late endosomes and lysosomes. Late endosomes and lysosomes can be characterized by the presence of components
such as antimicrobial peptides, lysosome-associated membrane
proteins (LAMPs), and lysosomal proteases (cathepsins B, D,
and L). In contrast to late endosomes, only lysosomes and
phagolysosomes contain significant amounts of mature proteases. In addition, the pH of lysosomes and phagolysosomes is
significantly lower (⬃pH 4.5) than the pH in late endosomes
(pH 5.5 to 6). The decrease in pH is due to the action of the
vacuolar proton ATPase (vATPase).
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TABLE 1. Strains used in this study
Strain

KIM6⫹
KIM6⫹/GFP
KIM6⫹/mCherry
KIM6⫹phoP
KIM6⫹ripCBA
KIM6
KIM5⫹
KIM5⫹/GFP
KIM5
KIM5/GFP
KIM10
32777

Relevant characteristics
⫺

⫹

⫹

pCD1 pPCP1 , pgm
pCD1⫺, pPCP1⫹, pgm⫹,
pMMB207gfp3.1, Cmr
pCD1⫺, pPCP1⫹, pgm⫹,
p207mCherry, Cmr
pCD1⫺, pPCP1⫹, pgm⫹ ⌬phoP
pCD1⫺, pPCP1⫹, pgm⫹ ⌬ripCBA
pCD1⫺, pPCP1⫹, ⌬pgm
pCD1Ap, pPCP1⫹, pgm⫹, Apr
pCD1Ap, pPCP1⫹, pgm⫹,
p207gfp3.1::kan, Knr Apr
pCD1Ap, pPCP1⫹, ⌬pgm, Apr
pCD1Ap, pPCP1⫹, ⌬pgm,
pMMB207gfp3.1, Apr Cmr
pCD1⫺, pPCP1⫺, ⌬pgm
pYV⫹

Reference

12
36
This study
13
This study
22
This study
This study
22
13
33
42

pestis. Instead, we find that Y. pestis prevents phagosome acidification, and it is suggested that this process allows Y. pestis to
avoid destruction in phagolysosomes or autophagolysosomes
of either naïve or activated macrophages.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The Y. pestis strains used (Table 1)
were derived from Y. pestis KIM (molecular group 2.MED) (1). Ampicillin
resistance (Apr), chloramphenicol resistance (Cmr), and kanamycin resistance
(aph-3⬘ or Knr) cassettes were introduced into Y. pestis strains in compliance with
CDC guidelines. Yersinia pseudotuberculosis strain 32777 (previously referred to
as strain IP2777) is a serogroup I isolate. Y. pestis strains were routinely grown on
heart infusion agar plates or in heart infusion broth at 28°C. Y. pseudotuberculosis
was grown in Luria-Bertani broth or on Luria-Bertani agar plates at 28°C. Y.
pestis was killed by fixation for 30 min with 2.5% paraformaldehyde, followed by
extensive washing with phosphate-buffered saline (PBS).
Strain construction. KIM6⫹ was converted to the fully virulent background by
introducing pCD1 marked with Apr (pCD1Ap) (12) via electroporation as described previously (13). The resulting strain was designated KIM5⫹ and is
handled according to select agent guidelines and using biosafety level 3 conditions. Screening for spontaneous loss of the pgm locus from KIM6⫹ (13) resulted
in KIM6. Introduction of pCD1Ap into KIM6 resulted in KIM5, a strain that is
conditionally virulent and exempt from select agent guidelines. Plasmid
pMMB207gfp3.1 (Cmr), used to express green fluorescent protein (GFP), was
introduced into KIM5 or KIM6⫹ by conjugation (13). A plasmid expressing
mCherry under control of the tac promoter was generated using pRSETmCherry (40). The mCherry gene was amplified from pRSET-mCherry by PCR
using oligonucleotides mCherry-EcoRI-F1 (5⬘-CCGGAATTCATGGTGAGCA
AGGGCGAG-3⬘) and mCherry-HindIII-R1 (5⬘-CCCAAGCTTTTACTTGTAC
AGCTCGTCCATGCC-3⬘). The mCherry coding region was inserted into
pMMB207 (27a) downstream of the tac promoter and between the EcoRI and
HindIII sites. The resulting plasmid, p207mCherry, was introduced into KIM6⫹
by conjugation. GFP or mCherry expression in Y. pestis was obtained by incubation in the presence of 500 M isopropyl-␤-D-thiogalactopyranoside (IPTG)
for 1 to 2 h.
To construct a Knr plasmid expressing inducible GFP, pMMB207gfp3.1 was
modified to inactivate the Cmr gene and to introduce a Knr cassette (aph-3⬘). To
this end, the Knr cassette was isolated from pBSL86 (2) by restriction digestion
with SmaI and inserted into the SnaBI site of pMMB207gfp3.1, resulting in
inactivation of the Cmr cassette. The resulting plasmid, p207gfp3.1::kan, was
conjugated into KIM5⫹, resulting in KIM5⫹/GFP.
Deletion of the ripCBA operon in KIM6⫹ was performed by allelic recombination. To this end, the ripCBA operon and flanking sequence were obtained by
PCR amplification using the KIM6⫹ chromosome as the template and primers
Y2382-F2-PvuII (5⬘-CAGCTGTTGACAACATCCAGAAATGCAATACCT3⬘) and Y2385-R5-XmaI (5⬘-TCCCCCCGGGTCAGATTAGATGCATTTTTT
TGGC-3⬘). The amplified DNA fragment was cloned into the pGEM-T Easy
vector (Promega). The resulting plasmid was digested with AfeI, which recognizes and cleaves sites within ripC and ripA. Upon ligation of the ends of the
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Early work on the trafficking of Y. pestis-containing vacuoles
(YCVs) in primary murine macrophages yielded evidence that
YCVs fuse with lysosomes (6, 45). It was therefore suggested
that Y. pestis survives in a phagolysosome (45). More recent
studies have confirmed that the YCV colocalizes with markers
of late endosomes or lysosomes in murine J774A.1 macrophage-like cells (13). Results of experiments that utilized lysosomal tracers or antibodies to the LAMP1 or cathepsin D
protein in conjunction with immunofluorescence and thin-section electron microscopy (EM) showed that the YCV colocalizes with these markers between 1.5 and 8 h postinfection (13).
In addition, results of ultrastructural analysis by thin-section
EM showed that the YCV has a spacious morphology beginning around 8 h postinfection, at which time bacterial replication begins (13). How Y. pestis controls phagosome trafficking
and expansion of its vacuole in macrophages is not understood.
Activation by the cytokine gamma interferon (IFN-␥) is
known to dramatically alter the trafficking and environment of
phagosomes in macrophages (37, 41). Y. pestis is able to survive
in primary murine macrophages that are activated with IFN-␥
(36). A chromosomally encoded operon termed ripCBA that
promotes survival of Y. pestis in activated macrophages has
been identified. The ripCBA genes appear to encode novel
metabolic enzymes (36). However, it is not known how the Rip
proteins promote intracellular survival, and it is unclear if the
morphology or trafficking of the YCV is modified in IFN-␥activated macrophages.
Autophagy is a membrane trafficking process in eukaryotic
cells that sequesters cytoplasmic material (e.g., defective mitochondria in the case of macroautophagy) in a vacuole (the
autophagosome) and routes the cargo for destruction in an
autophagolysosome (19, 21, 28). The autophagy pathway encompasses several different membrane compartments, beginning with the phagophore, which functions to sequester cytoplasmic material. Following trapping of cytoplasmic material
by the phagophore, the autophagosome is formed, which matures through interactions with late endosomes and lysosomes
into an autophagolysosome, where degradation of luminal
components takes place. Autophagy is regulated at multiple
steps by several signaling molecules, including the mTOR kinase and class I and class III phosphatidylinositol 3-kinases
(19, 21, 28). Recent studies have revealed that autophagy can
play an important role in the protective innate immune response to cytoplasmic or vacuolar bacterial pathogens (3, 21,
28). The process that results in breakdown of microorganisms
within autophagosomes has been referred to as xenophagy
(21). IFN-␥ can upregulate autophagy in macrophages (21). In
macrophages exposed to IFN-␥, upregulation of autophagy
appears to override the phagosome maturation block imposed
by Mycobacterium tuberculosis, allowing routing of the pathogen to a microbicidal autophagolysosome-like compartment
(21, 28). Alternatively, some intracellular pathogens appear to
co-opt autophagy for survival within host cells (26, 28).
In this work we examined the possibility that the replication
of Y. pestis in macrophages exposed to IFN-␥ resulted from an
increase in autophagy and that the pathogen might exploit this
process for survival within phagosomes. Our results show that,
although the YCV can interact with an autophagy pathway in
macrophages, this interaction does not appear to require activation by IFN-␥ nor is it required for intracellular survival of Y.
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ond retroviral harvest (ratio, 2:1). Twenty-four hours posttransduction, the supernatant of transduced BMDMs was removed and replaced with fresh BMDM
infection medium (DMEM with Glutamax-I supplemented with 10% FBS, 15%
L-cell-conditioned supernatant, and 1 mM sodium pyruvate), and the preparation was incubated for a minimum of 30 min before infection.
Determination of colocalization of GFP-LC3 with YCVs by fluorescence microscopy. BMDMs were infected with KIM6⫹/mCherry and treated or not
treated with IFN-␥ as described previously (36). IPTG was added to the cell
culture media 2 h before the end of a time point to induce mCherry expression.
At the time indicated below, the infected cells were fixed with 2.5% paraformaldehyde and processed for immunofluorescence labeling (35). Bacteria were
stained with anti-Yersinia primary antibody (35) and a goat anti-rabbit secondary
antibody conjugated to Alexa Fluor 633 (Molecular Probes) for confocal microscopy analysis or to Alexa Fluor 594 (Molecular Probes) for epifluorescence
analysis. GFP-LC3 was immunolabeled using an anti-GFP monoclonal antibody
diluted 1:250 (catalog no. A11120; Invitrogen) and a goat anti-mouse antibody
conjugated to Alexa Fluor 488 to enhance detection. Confocal images were
acquired using a Zeiss inverted Axiovert 200 M microscope. GFP-LC3-positive
YCVs were quantified by epifluorescence microscopy using a Zeiss Axioplan2
microscope equipped with a ⫻40 objective. Images were captured using a Spot
camera (Diagnostic Instruments, Inc.) and assembled in Adobe Photoshop.
GFP-LC3-positive YCVs were enumerated using merged images of green fluorescence (combined GFP and Alexa Fluor 488) and red fluorescence (combined
mCherry and Alexa Fluor 594), and the results were expressed as a percentage
obtained by dividing the number of YCVs positive for LC3-GFP by the total
number of YCVs. Approximately 300 YCVs were enumerated for each condition
in a single experiment.
Phagosomal pH assays. Determination of Lysotracker Red DND-99 colocalization with YCVs containing Y. pestis was performed using J774A.1 macrophage-like cells as described previously for Texas Red ovalbumin (13), except
that Lysotracker was added at a concentration of 50 nM 1 h prior to fixation and
analysis of samples. In some experiments macrophages were incubated in medium containing 30 g/ml chloramphenicol to inhibit bacterial protein synthesis
during infection. Coinfection experiments were performed as follows. KIM5/
GFP bacteria were induced with IPTG (500 M) to express GFP and then fixed.
Macrophages were infected at an MOI of 5 with fixed KIM5/GFP and unlabeled
live KIM5 (total MOI, 10). At 1.25 h postinfection cells were fixed, permeabilized
with saponin, and stained with anti-Yersinia primary antibody (1:1,000) and Alexa
Fluor 350 (Molecular Probes) secondary antibody (1:500). Macrophages were
labeled with Lysotracker as described above.
The YCV pH was measured by ratiometic imaging as described previously
(43), with the following modifications. Y. pestis was labeled with fluorescein
isothiocyanate (FITC) at a final concentration of 1 mg/ml in PBS (pH 8) for 30
min. After three washes in PBS, the bacteria were used to infect J774A.1 cells
seeded in 35-mm glass coverslip dishes as described previously (13). A Zeiss LSM
510 META microscope was used for live cell analysis. Images were obtained
using excitation wavelengths of 488 nm and 458 nm. The pH of YCVs was
extrapolated from a calibration curve (pH 4 to 7) generated using 10 M
monensin and 10 M nigericin (43). Signal intensities of at least 50 phagosomes
were determined in three different fields per experiment.

RESULTS
Fully virulent Y. pestis replicates in activated macrophages.
We previously demonstrated that Y. pestis cured of pCD1
(KIM6⫹) (Table 1) replicates in murine BMDMs activated
with IFN-␥ (36). To determine if fully virulent, pCD1-containing Y. pestis can survive in activated BMDMs, a GFP induction
assay was performed (35). KIM5⫹/GFP (Table 1) pregrown at
28°C was used to infect BMDMs, and survival of extracellular
bacteria was prevented by use of gentamicin (see Materials and
Methods). At different time points postinfection de novo synthesis of GFP was induced by addition of IPTG, and live cells
were examined using phase-contrast and fluorescence microscopy. As shown in Fig. 1, KIM5⫹/GFP replicated in activated
in BMDMs between 6 and 24 h postinfection. At a higher
magnification, GFP-positive bacteria were clearly visible within
spacious YCVs of activated BMDMs at 24 h postinfection (Fig.
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plasmid, a deletion was obtained that removed the 3⬘ end of ripC, all of the ripB
gene, and the 5⬘ end of ripA. A DNA fragment with the deletion (⌬ripCBA) was
liberated from pGEM-T Easy and introduced into the suicide vector pSB890
using NotI restriction sites (30). The resulting plasmid, pSB890⌬ripCBA, was
conjugated into KIM6⫹, and allelic exchange was performed as described previously (14), resulting in KIM6⫹ripCBA.
Cell culture. Bone marrow-derived macrophages (BMDMs) were isolated and
cultured as described previously (35, 36). BMDMs were prepared from femurs of
C57BL/6 mice (Jackson Laboratory), ATG5flox/flox-Lyz-Cre mice, or control
ATG5flox/flox mice (52). ATG5flox/flox mice were backcrossed five generations
to a C57BL/6 line prior to use. 293T cells were cultivated at 37°C in the presence
of 5% CO2 in Dulbecco modified Eagle medium (DMEM) with Glutamax-I
(Invitrogen) supplemented with 1 mM sodium pyruvate (Invitrogen) and 10%
fetal bovine serum (FBS) (HyClone). J774A.1 murine macrophage-like cells
were cultured as described previously (13).
Assays for determination of bacterial survival in macrophages. The procedures used for infecting macrophages with Y. pestis or Y. pseudotuberculosis and
for measuring intracellular survival by a CFU or GFP induction assay have been
described previously (13, 35, 36).
EM. BMDMs (1.5 ⫻ 105 cells) seeded on plastic coverslips (diameter, 12 mm;
Thermanox) were infected with KIM5⫹ at a multiplicity of infection (MOI) of 10
for 30 min in 200 l of infection medium. Activation of BMDMs with IFN-␥ was
performed as described previously (36). At the appropriate time, the infected
cells were fixed for 1 h with a mixture of 2% paraformaldehyde and 2.5%
glutaraldehyde in 100 mM cacodylate buffer (pH 7.5) supplemented with 2.5 mM
CaCl2. Fixative buffer baths were renewed after 30 min of incubation. Fixed
samples were washed three times for 5 min with 100 mM cacodylate buffer (pH
7.5) and processed by the Central Microscopy Image Center at Stony Brook
University. Digital images of thin sections were acquired with an FEI BioTwinG2
transmission electron microscope.
Detection of LC3 by immunoblotting. BMDMs (6.5 ⫻ 105 cells) seeded in
six-well plates were infected with Y. pestis strains as previously described (35),
with the following modifications. An MOI of 10 to 15 was used, and BMDMs
were infected for 30 min in a small volume (1 ml) of infection medium. BMDMs
were activated by adding 150 U/ml IFN-␥ to the infected wells as previously
described (36). Twenty-four hours postinfection, the infected cells were washed
three times with PBS and lysed with 100 l RIPA buffer (150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 50 mM Tris [pH 8.0], 0.1% sodium dodecyl
sulfate [SDS]) containing protease inhibitors (Complete Mini, EDTA-free;
Roche). Cell lysate from each well was collected, passed through a 22-gauge
needle, and centrifuged for 10 min at 16,000 ⫻ g at 4°C. Supernatants were
collected, protein concentrations were determined (bincinchoninic acid or Bradford protein assay), and 25 g of protein from each sample was separated by
SDS-polyacrylamide gel electrophoresis (15% polyacrylamide) and transferred
onto a 0.2-m polyvinylidene difluoride membrane for 2 h at 100 V using a
MiniBiorad electrophoresis apparatus. The blots were probed overnight using a
polyclonal anti-LC3 antibody (catalog no. NB100-2331; Novus) diluted 1:300 in
Tris-buffered saline–0.05% Tween containing 5% dry skim milk. To control for
loading, blots were probed with a polyclonal anti-actin antibody (catalog no.
4967; Cell Signaling). Secondary rabbit immunoglobulin G antibody conjugated
to horseradish peroxidase (catalog no. 111-035-144; Jackson Immunoresearch)
was used at a dilution of 1:5,000. Immunoblots were developed using an enhanced chemiluminescent reagent (Perkin-Elmer Life Science) and Kodak XMAT film. Band intensities for LC3-II, LC3-I, and ␤-actin were quantified using
QuantityOne software (Bio-Rad), and ratios of LC3-II to LC3-I or LC3-II to
actin were calculated.
Transfection of 293T cells and production of retroviral particles. 293T packaging cells (4 ⫻ 106 cells) were seeded in 100-mm cell culture-treated dishes 16 h
before transfection. Six micrograms of pCL-Eco (Imgenex) and 6 g of pJC110
expressing GFP-LC3 (a gift from Jean Celli) (7) were added to the cell culture
medium using the HEPES-buffered saline calcium phosphate method (31).
Seven hours later, the supernatant of transfected 293T cells was replaced with
fresh cell culture medium and the preparation was incubated overnight. The
supernatant containing retroviral particles was collected, centrifuged for 10 min
at 834 ⫻ g, and passed through a 0.45-m filter. A second supernatant was
obtained after 8 h of incubation with fresh cell culture medium and processed as
described above.
Retroviral transduction of BMDMs. BMDMs seeded on coverslips in 24-well
plates at a concentration of 6 ⫻ 104 cells/well and grown for 2 days were
transduced with a 2:1 mixture of retrovirus-containing supernatant (first collection) and BMDM culture medium (DMEM with Glutamax-I supplemented with
20% FBS, 1 mM sodium pyruvate, and 45% L-cell supernatant). After 8 h, the
supernatant was replaced with fresh BMDM culture medium containing the sec-
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2), with elongated bacteria typically apposed to the phagosomal membrane.
Ultrastructural analysis of YCV morphology in activated
macrophages. We next looked for evidence that YCVs interact
with an autophagy pathway in activated macrophages. Evidence for the interaction of intracellular bacteria with an autophagy pathway can be obtained by analysis of phagosome
morphology at the ultrastructural level (19). Nascent autophagosomes typically have a double membrane. Fusion of lysosomes with an autophagosome results in maturation of the
vacuole to an autophagolysosome, which has a single delimiting membrane. Therefore, the presence of a double membrane
surrounding an intracellular bacterium can be taken as evidence that the pathogen was residing in a nascent autophagosome-like vacuole at the time of cell fixation. Thin-section EM
was used to examine the possibility that Y. pestis resides in
autophagosome-like vacuoles in activated macrophages.
BMDMs were infected with KIM5⫹ (Table 1) pregrown at
28°C and then exposed to IFN-␥. Analysis of the infected

macrophages at 4 h postinfection by thin-section EM (see
Materials and Methods) showed that some intracellular Y.
pestis bacteria were present within a tight-fitting double membrane (Fig. 3A and B). However, more commonly, a tightfitting single membrane surrounded intracellular Y. pestis and
other vesicular material (Fig. 3C). At a later time point (22 h
postinfection) Y. pestis bacteria were found to be present in
spacious phagosomes with partial double membranes (Fig. 3D
and E and Fig. 3F, inset). These results indicated that, in
activated macrophages, Y. pestis resided in autophagosomelike vacuoles, as well as in vacuoles with morphologies similar
to those of standard phagosomes or multivesicular bodies.
IFN-␥ and replication of Y. pestis increase LC3-II levels in
macrophages. The progress of autophagy is executed by ATG
proteins, which comprise two protein conjugation systems. The
ATG8 protein (more commonly known as LC3-I in its unconjugated form) becomes conjugated to phosphatidylethanolamine during autophagy, resulting in the formation of LC3-II,
which specifically associates with autophagic membranes (19).

FIG. 2. Examination of Y. pestis-containing spacious phagosomes in activated macrophages by microscopy. (A and B) Enlargements of regions
of panels C and D of Fig. 1, respectively. (C) Overlay of panels A and B.
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FIG. 1. Analysis of Y. pestis replication in activated macrophages by microscopy. BMDMs infected with KIM5⫹/GFP were activated with IFN-␥
and incubated for 6 h (A and B) or 24 h (C and D) before microscopic examination. One hour before examination, IPTG was added to induce
de novo expression of GFP in viable intracellular bacteria. (A and C) Representative phase-contrast microscopy images. (B and D) Representative
fluorescence microscopy images.
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The conversion of LC3-I to LC3-II and the turnover or degradation of LC3-II within autophagolysosomes can be followed
by immunoblotting, and this procedure has become a useful
tool for measuring rates of autophagy within eukaryotic cells
(19, 27). The steady-state level of LC3-II, as detected by immunoblotting of cell lysates, was used to determine if autophagy was altered in macrophages after 24 h of treatment with
IFN-␥ and/or infection by Y. pestis KIM6⫹. The LC3-II signal
obtained by immunoblotting was normalized by using two different approaches (19), calculating the ratio of LC3-II to LC3-I
and calculating the ratio of LC3-II to a loading control (actin).
Treatment of uninfected BMDMs with IFN-␥ resulted in an
increased ratio of LC3-II to LC3-I compared to that for untreated macrophages (Fig. 4A, compare lanes 3 and 4; Fig. 4B).
Interestingly, after infection of BMDMs with Y. pestis KIM6⫹
in the absence of IFN-␥, there were large increases in the
steady-state levels of both LC3-I and LC3-II (Fig. 4A, compare
lanes 1 and 3) and there was a slight increase in the LC3-II/
LC3-I ratio compared to the data for uninfected macrophages
(Fig. 4B). Infection of BMDMs with KIM6⫹ in the presence of
IFN-␥ resulted in a further increase in the LC3-II/LC3-I ratio
(Fig. 4A, lane 2; Fig. 4B). A time course analysis indicated that
the increased LC3-II level was observed beginning at 3 h
postinfection (data not shown). To determine if the increase in
the LC3-II level required survival of Y. pestis in macrophages,
BMDMs were infected with a KIM6⫹ phoP mutant (Table 1),
which is defective for intracellular survival, or with killed formaldehyde-fixed KIM6⫹. Compared to the data for macrophages infected with live KIM6⫹, the LC3-II/actin ratios were
lower after challenge with the phoP mutant or fixed KIM6⫹

(Fig. 4C and D). Moreover, the LC3-II/actin ratio was higher
in BMDMs infected with a Y. pestis strain containing pCD1 but
lacking the pgm locus (KIM5) (Table 1) than in uninfected
BMDMs (Fig. 4E and F), although in this case the ratios were
higher in nonactivated macrophages than in IFN-␥-treated
BMDMs (Fig. 4E and F). We have observed that KIM5 does
not replicate in activated BMDMs as well as KIM6⫹ replicates, in part because it lacks the ripCBA operon in the pgm
locus (36). A KIM6⫹ ripCBA mutant (Table 1) had a phenotype similar to that of KIM5 with respect to LC3-II levels (Fig.
4E and F). These results indicated that the levels of LC3-II in
macrophages could be increased by treatment with IFN-␥ or by
infection with replicating Y. pestis.
Analysis of GFP-LC3 colocalization with YCVs in macrophages. A GFP-LC3 fusion protein can be used as a specific
cytological marker for autophagic membranes in eukaryotic
cells (19). Fluorescence microscopy was used to quantify the
GFP-LC3 in YCVs in macrophages exposed or not exposed to
IFN-␥. For this purpose, BMDMs were transduced with a
retrovirus producing GFP-LC3 (see Materials and Methods).
One day after transduction, BMDMs were infected with
KIM6⫹/mCherry (Table 1) in the presence or absence of
IFN-␥. IPTG was added to the infected wells for 2 h to induce
de novo mCherry expression in viable intracellular Y. pestis.
Eight hours postinfection, the infected wells were fixed and the
samples were processed for immunofluorescence microscopy
(see Materials and Methods). The colocalization of GFP-LC3
and bacterial signals was determined by confocal fluorescence
microscopy. As shown in Fig. 5B, GFP-LC3 could be detected
on YCVs in macrophages that were treated with IFN-␥, con-
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FIG. 3. YCV morphology in activated macrophages as determined by thin-section EM. BMDMs were infected with KIM5⫹ and then treated
with IFN-␥. At 4 h (A to C) or 22 h (D to F) the cells were fixed and processed for thin-section EM. (A) BMDM infected with KIM5⫹ at 4 h
postinfection. (B) Magnification of area containing bacteria in panel A. The arrow indicates a double membrane surrounding a single bacterium.
(C) BMDM infected with KIM5⫹ at 4 h postinfection, showing two bacteria and other vesicles in a single-membrane compartment. (D) BMDM
infected with KIM5⫹ for 22 h. The arrow indicates a region with a double membrane. (E) Magnification of a region in panel D. (F) BMDM
infected with KIM5⫹ for 22 h. A region containing a double membrane is magnified in the inset. (A) Bar ⫽ 2 m. (B to F) Bars ⫽ 500 nm.
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FIG. 5. Analysis of GFP-LC3 colocalization with YCVs. BMDMs
were transduced with retrovirus producing GFP-LC3. Twenty-four
hours posttransduction, the macrophages were infected with KIM6⫹/
mCherry. De novo expression of mCherry was induced in viable intracellular bacteria by addition of IPTG. After 8 h of infection with Y.
pestis in the absence (A) or presence (B) of IFN-␥, cells were fixed and
processed for examination by fluorescence microscopy. Images were
obtained by using confocal fluorescence microscopy. The panels show
overlays of GFP-LC3 (green) and mCherry (red) signals from representative images. The percentages of colocalization of signals as determined by epifluorescence microscopy are shown for each condition,
and the numbers of phagosomes scored are indicated in parentheses.

firming that an autophagic membrane can be recruited to
phagosomes containing viable Y. pestis, as suggested by transmission EM results (Fig. 3B). However, quantification by epifluorescence microscopy showed that only 30.4% of YCVs in
activated macrophages were positive for GFP-LC3 (Fig. 5B). In
addition, a slightly higher percentage of YCVs colocalized with
GFP-LC3 in naïve macrophages (42.5%) (Fig. 5A). Thus, although Y. pestis infection modulated autophagy, based on increased steady-state levels of LC3-II (Fig. 4), the majority of
YCVs did not colocalize with the GFP-LC3 marker of autophagic
membranes in BMDMs. It was anticipated that the percentage of
GFP-LC3-positive YCVs would be highest in activated macrophages, conditions under which maximal LC3-II levels were seen
(Fig. 4), but this was not the case (see Discussion).
Y. pestis inhibits phagosome acidification. The results described above suggested that the localization of an autophagic
membrane to YCVs and the increase in LC3-II levels during
infection may not be critical for intracellular survival, but
rather a side effect or downstream consequence of the strategy
that Y. pestis uses to survive in macrophages. Turnover of
LC3-II trapped in autophagosomes is mediated by lysosomal
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FIG. 4. Immunoblot analysis of LC3 levels in BMDMs exposed to IFN-␥ and infected with Y. pestis. BMDMs were not infected or were infected
with KIM6⫹ in the presence or absence of IFN-␥. At 24 h postinfection cell lysates were prepared and subjected to SDS-polyacrylamide gel
electrophoresis, followed by immunoblotting with anti-LC3 antibody (A, C, and E) and anti-actin antibody (C and E). For panels C and E,
macrophages were infected with the KIM6⫹ phoP mutant, with KIM6⫹ fixed with paraformaldehyde, with KIM5, or with the KIM6⫹ ripCBA
mutant. Densitometry was used to quantify band signals for LC3-I and LC3-II (A) or for LC3-II and actin (C and E), and calculated ratios are
shown in panels B, D, and F, respectively. For panel B the ratio of LC3-II to LC3-I in uninfected and untreated cells was defined as 1, and other
ratios were normalized to this value.
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proteases which are activated in autophagolysosomes. Preventing lysosomal degradation by use of protease inhibitors or
drugs (such as bafilomycin A1) that inhibit vacuole acidification leads to an increase in the steady-state level of LC3-II
(19). Y. pseudotuberculosis, which is closely related to Y. pestis
(1), has been shown to inhibit acidification of phagosomes in
primary murine macrophages (46). To determine if Y. pestis
prevents acidification of phagosomes, colocalization of YCVs
with a probe for acidic lysosomes (Lysotracker DND-99) in
macrophages was assayed by fluorescence microscopy. When
naïve J774A.1 murine macrophage-like cells were infected with
KIM5/GFP (Table 1) in the presence of Lysotracker, very few
GFP-positive YCVs colocalized with Lysotracker up to 5 h
postinfection (Fig. 6A to C and G). In contrast, phagosomes
containing killed fixed KIM5/GFP showed increased colocalization with Lysotracker with time, and the value reached 90%
by 2.5 h postinfection (Fig. 6D to F and G). This result suggested that live Y. pestis could prevent acidification of the
YCVs to values below the value required for detection of
Lysotracker (pH ⱕ5.5).
We next used live cell ratiometric imaging and Y. pestis
labeled with the pH-sensitive dye FITC to measure the pH of
the YCV over a time course (43). As shown in Fig. 7, the pH

FIG. 7. Measurement of YCV pH using live cell ratiometric imaging. Live KIM5 cells, fixed KIM5 cells, or live 32777 cells labeled with
FITC were used to infect J774A.1 macrophages. At the indicated time
points live cell imaging was performed using a confocal microscope.
Images were obtained by using excitation wavelengths of 488 nm and
458 nm. A calibration curve was generated using the ionophores monensin and nigericin and media buffered at pHs between pH 4 and 7.
Comparison of the 488 nm/458 nm ratio to the pH calibration curve
was used to estimate the pH of YCVs. The symbols indicate the
averages of three experiments (for 32777) or of five experiments (for
KIM5 and fixed KIM5), and the error bars indicate standard deviations.
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FIG. 6. Measurement of YCV acidification using Lysotracker and fluorescence microscopy. J774A.1 macrophages on coverslips were infected with
live KIM5/GFP (A to C) or fixed KIM5/GFP (D to F) in the presence of Lysotracker Red DND-99. At 1.25 h postinfection the samples were fixed, and
representative images were obtained by using a fluorescence microscope equipped with a digital camera. The images show the GFP signal (A and D),
the Lysotracker signal (B and E), or an overlay of the two signals (C and F). (G) Percent colocalization of GFP and Lysotracker signals at the indicated
time points, as quantified using three independent experiments. The symbols indicate averages, and the error bars indicate standard deviations.
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FIG. 8. CFU assay of Y. pestis survival in ATG5flox/flox-Lyz-Cre
BMDMs or control ATG5flox/flox BMDMs. BMDMs prepared from
ATG5flox/flox-Lyz-Cre mice (Atg5⫺/⫺) or control ATG5flox/flox mice
(Atg5⫹/⫹) were infected with KIM5 or the KIM5 phoP mutant at an
MOI of 10. After 20 min of infection the macrophages were washed to
remove nonadherent bacteria and then incubated in medium containing gentamicin to kill extracellular bacteria. At the indicated time
points washed macrophages were lysed in detergent, and serial dilutions were plated to enumerate CFU. The data are values from three
independent experiments, and the error bars indicate standard deviations. An asterisk indicates a significant difference (P ⬍ 0.01) compared to the data for the 20-min time point for the same group, as
determined by one-way analysis of variance with Dunnett’s posttest.

and in the absence of chloramphenicol (data not shown). To
determine if chloramphenicol was effectively inhibiting bacterial protein synthesis under the conditions used for the infection assay, macrophages were infected with KIM5/GFP that
had not been preinduced to express GFP. GFP expression was
not upregulated in bacteria in chloramphenicol-treated macrophages following addition of IPTG, showing that the antibiotic effectively inhibited de novo protein synthesis. The results
of a coinfection experiment with live and fixed KIM5 showed
that live bacteria were unable to prevent colocalization of
Lysotracker with phagosomes containing fixed bacteria when
they were in the same macrophage (data not shown). Taken
together, these results suggest that Y. pestis is able to inhibit
phagosome acidification using a factor(s) that is produced by
the pathogen prior to phagocytosis and that this factor does
not act globally within the macrophage to inhibit phagosome
acidification.
Inhibition of phagosome acidification by Y. pestis does not
require known virulence factors. KIM10, a Y. pestis strain lacking pCD1, pPCP1, and the pgm locus (Table 1), was tested for
the ability to prevent phagosome acidification in J774A.1 cells.
The results of a Lysotracker assay with KIM10 showed that
genes in pCD1, pPCP1, or the pgm locus were not required to
prevent phagosome acidification (data not shown). In addition,
although a Y. pestis phoP mutant is defective for intracellular
survival, phagosomes containing the KIM6⫹ phoP mutant did
not colocalize with Lysotracker for the limited period during
which the bacteria remained intact within macrophages, suggesting that the factor(s) required to inhibit phagosome acidification is not under control of the PhoP regulon.
DISCUSSION
Several species of pathogenic bacteria subvert the function
of macrophages in order to survive and replicate within these
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of phagosomes containing live KIM5 was ⬃6.5 at 30 min
postinfection. Over the next several hours the pH of the YCV
was determined to be ⬃8, confirming the finding of the Lysotracker assay that Y. pestis inhibits phagosome acidification.
Similar results were obtained for Y. pseudotuberculosis 32777
(Table 1) (Fig. 7), confirming that this property is shared by the
two Yersinia species. In contrast, the pH of YCVs containing
fixed KIM5 decreased to ⬃4.5 within 2.5 h (Fig. 7). These
results showed that Y. pestis inhibits acidification of its phagosomes, regardless of whether it acquires an autophagic membrane, and prevents maturation of these vacuoles. Thus, in the
YCVs that incorporate an autophagic membrane, the normal
turnover of LC3-II may be prevented, resulting in accumulation of this autophagy marker.
Autophagy is dispensable for survival of Y. pestis in macrophages. Based on the results described above (Fig. 5 to 7), we
predicted that autophagy is dispensable for survival of Y. pestis
in macrophages, and to test this hypothesis, we utilized
BMDMs deficient for this process. In many studies, 3-methyladenine, an inhibitor of class I and class III phosphatidylinositol 3-kinases, is used to pharmacologically block autophagy in
cells. In preliminary control experiments we found that growth
of Y. pestis in bacterial culture media was inhibited in the
presence of 5 mM 3-methyladenine, a concentration that is
typically used to block autophagy in cells. We therefore sought
an alternative approach to block autophagy that did not involve the potential nonspecific effects of chemical inhibitors.
The ATG5 protein is essential for autophagy, as it is required
for the formation of the phagophore (19, 21). Mice lacking
ATG5 in myelomonocytic cells have been generated by breeding ATG5flox/flox mice with mice in which Cre recombinase is
expressed from the lysozyme M locus (52). BMDMs derived
from the ATG5flox/flox-Lyz-Cre mice are defective for autophagy and have been used previously to determine the role of
autophagy in coronavirus replication in host cells (52).
BMDMs prepared from ATG5flox/flox-Lyz-Cre mice or control ATG5flox/flox mice were infected with Y. pestis. Immunoblotting for LC3-I and LC3-II confirmed that the ATG5flox/
flox-Lyz-Cre BMDMs were defective for autophagy (data not
shown) (52). The BMDMs were infected with KIM5 or the
KIM5 phoP mutant, and a CFU assay (see Materials and
Methods) was performed at different time points after infection. As shown in Fig. 8, KIM5 survived equally well in
BMDMs from ATG5flox/flox-Lyz-Cre mice and BMDMs from
control ATG5flox/flox mice. The phoP mutant showed a similar
survival defect in both types of macrophages (Fig. 8). Therefore, although YCVs can interact with an autophagy pathway
in macrophages, recruitment of an autophagic membrane does
not appear to be required for survival of Y. pestis in phagosomes. Instead, a primary mechanism of Y. pestis survival in
macrophages seems to be inhibition of YCV acidification.
Inhibition of phagosome acidification by Y. pestis does not
require de novo bacterial protein synthesis. To determine if de
novo bacterial protein synthesis was required for Y. pestis to
inhibit phagosome acidification, J774A.1 macrophages were
infected in the presence of the bacteriostatic antibiotic chloramphenicol at a final concentration of 30 g/ml. The results of
a Lysotracker assay performed between 1.5 and 5 h postinfection showed that there was no difference in the ability of
KIM5/GFP to inhibit phagosome acidification in the presence
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GFP-LC3 to the YCV (Fig. 5), which may represent a protective response on the part of the macrophage to prevent sequestration of autophagic membrane by the pathogen.
The ability to prevent phagosome acidification appears to be
an attribute common to several pathogenic bacteria (17). As
discussed above for M. tuberculosis, the arrest in maturation of
its phagosome precludes acquisition of a sufficient density of
vATPase, and the failure to acidify is most likely a consequence of the block in membrane trafficking (17). It is currently unclear how Y. pestis prevents phagosome acidification.
It is possible that, like M. tuberculosis, Y. pestis prevents association of the vATPase with the YCV. Alternatively, the
vATPase may associate with the YCV but is inactivated, as has
been suggested for Y. pseudotuberculosis (46). The use of antivATPase antibodies in conjunction with microscopy techniques
should allow us to distinguish between these possibilities.
Recently, Listeria monocytogenes has been shown to be capable of replicating slowly in macrophage phagosomes that
expand and do not acidify (4). The pore-forming hemolysin
listeriolysin O is required for this process, and it was suggested
that pore formation by listeriolysin O allows dissipation of the
pH gradient (4). Y. pestis is not known to secrete a poreforming hemolysin, and analysis of the sequenced genome
does not reveal predicted proteins with significant homology to
pore-forming hemolysins (unpublished observations). The putative factor that Y. pestis secretes to inhibit phagosome acidification appears to be produced by the bacterium prior to
macrophage interaction, and it appears to act on or within the
phagosome in a local manner. There is precedence for the
production of vATPase-inhibiting molecules by microorganisms (e.g., bafilomycin A1), but to our knowledge there is no
known bacterial factor that can mediate this activity directly. It
is not inconceivable that a bacterial protein secreted in a
phagosome could inhibit the vATPase. The V0 domain of the
vATPase is exposed on the luminal side of the vacuole, and
there is previously obtained evidence that a monoclonal antibody that is specific for the a subunit of the V0 domain can
inhibit vATPase activity when this antibody resides in the endosomal compartment (38).
Straley and Harmon showed that genes in pCD1, pPCP1,
and the pgm locus were not required for replication of Y. pestis
in murine macrophages (44). Using a Lysotracker assay, we
found that these genetic elements are also not required for
inhibition of phagosome acidification by Y. pestis. The phoP
gene is important for survival of Y. pestis in macrophages (29).
PhoP-regulated genes important for survival of S. enterica serovar Typhimurium in the phagosomes of macrophages include genes of the pmr operon. The products of the pmr
operon function to modify lipid A with aminoarabinose; this
increases bacterial resistance to antimicrobial peptides (10,
15). Genes under control of PhoP in Y. pestis that are important for survival in macrophages include ugd, pmrK, and mgtC,
which are predicted to promote resistance to antimicrobial
peptides (ugd and pmrK) or low-Mg2⫹ conditions (mgtC) of a
phagosome (13). Phagosomes containing Y. pestis phoP mutants do not colocalize with Lysotracker for the period of time
that the bacteria remain intact within macrophages. This result
indicates that inhibition of phagosome acidification is not sufficient for intracellular survival of Y. pestis; resistance to antimicrobial peptides and resistance to environmental stress en-
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cells. Examples include Francisella, Brucella, Legionella, Listeria, Mycobacterium, and Salmonella species. These bacteria
escape from the phagosome and replicate in the macrophage
cytosol or modify the phagosome to reach a replicative niche.
Pathogenic bacteria that survive within macrophage phagosomes utilize several different strategies to avoid being killed in
a vacuole that could potentially mature into a phagolysosome
(9, 24). M. tuberculosis survives within macrophages by stalling
maturation of its vacuole at an early stage. The mycobacterial
phagosome is characterized by the absence of a number of
markers that are usually associated with late endosomes (37,
47). For example, Mycobacterium inhibits acidification of its
vacuole by preventing the accumulation of vATPase. Mature
lysosomal proteases are also excluded from the mycobacterial
phagosome.
We have shown that the YCV has an unusual trafficking
pattern as it can acquire markers of late endosomes (LAMP1
and cathepsin D) (13) and autophagosomes (GFP-LC3) (Fig.
5), yet it does not undergo acidification (Fig. 6 and 7). It is
thought that acidification is required for efficient phagosomelysosome or autophagosome-lysosome fusion (17, 28, 49). We
hypothesize that the YCV fuses with several vesicular compartments, including late endosomes, multivesicular bodies,
and autophagosomes, but fusion with lysosomes and thus full
maturation of the YCV are inefficient due to its lack of acidification. The observation that Y. pestis infection results in
increased steady-state levels of LC3-II (Fig. 4) is consistent
with this model, since LC3-II turnover would be prevented in
nonacidified autophagosomes. We previously showed that Y.
pestis could replicate in BMDMs exposed to IFN-␥ (36). IFN-␥
treatment is known to stimulate autophagy, and some pathogens appear to hijack the autophagy pathway for intracellular
replication (26, 28). However, in some cases IFN-␥-induced
autophagy is protective, leading to efficient killing (i.e., xenophagy) of intracellular bacteria, such as M. tuberculosis. Our
results suggest that Y. pestis has a strategy to avoid the protective role of xenophagy in either naïve or activated phagocytes
and that the increase in the steady-state levels of LC3-II in Y.
pestis-infected macrophages is an effect, rather than a cause, of
YCV formation.
Although results described here indicate that autophagy is
not required for survival of Y. pestis in macrophage phagosomes (Fig. 8), it is possible that recruitment of an autophagic
membrane to the YCV has important consequences for the
outcome of the pathogen-host interaction. Autophagosomes
may provide a source of membrane, along with late endosomes, for expansion of the YCV into a spacious compartment.
Alternatively, recruitment of an autophagic membrane to the
YCV may prevent use of the autophagy pathway for its normal
functions in macrophages, such as clearing damaged mitochondria or survival during starvation or growth factor withdrawal.
There is evidence that death of macrophages infected with
Salmonella enterica serovar Typhimurium can occur by autophagy (16). We suggest that recruitment of an autophaghic
membrane to the YCV and prevention of LC3-II turnover
allow intracellular Y. pestis to slowly compromise the viability
of the macrophage. This could provide a mechanism for release of the bacteria from the dying host cell once an intracellular replication cycle has been completed. In this context, we
observed that treatment with IFN-␥ decreased recruitment of
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countered within the YCV are also important for replication of
the pathogen in macrophages. Further understanding of the
mechanism by which Y. pestis inhibits phagosome acidification
requires identification of genes essential for this process.
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